Ireland
--:--IST
Latest
Clinical Trials in Sweden / NCT07434908
Recruiting Observational

Heparin-binding Protein and Lungedema in ICU Patients.

NCT07434908 · tracked via the Priya Life Science Sweden tracker
Phase
Observational
Started
2024-05-06
Last updated
2026-03-10

Condition(s) studied

Lung Edema

Study summary

The goal of this single center observational cohort study is to investigate the relationship between physiological measures of lung oedema, and the biomarker Heparin-binding Protein (HBP).

The main questions it aims to answer are:

* Does the concentration of HBP in plasma correlate with measures of lung vascular permeability and extravascular water in the lungs?
* Does the concentration of HBP in plasma correlate with the patient's total accumulated fluid balance?

Researchers will collect blood samples and gather information on lung vascular permeability and extravascular lung water in Intensive care patients who are provided with a hemodynamic surveillance system called PiCCO. The study will include 25 patients.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Patients \>18 years * Monitored with a PiCCO system Exclusion Criteria: • Patients transferred from another ICU

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
ICU Östersund Sweden Recruiting

More Umeå University trials in Sweden

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07434908 on ClinicalTrials.gov ↗ ← All trials in Sweden